<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03720691</url>
  </required_header>
  <id_info>
    <org_study_id>18-0089</org_study_id>
    <nct_id>NCT03720691</nct_id>
  </id_info>
  <brief_title>rTMS Treatment in Vascular Parkinsonism</brief_title>
  <acronym>rTMS</acronym>
  <official_title>Effect of Repetitive Transcranial Magnetic Stimulation in Vascular Parkinsonism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dongtan Sacred Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Inje University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vascular parkinsonism (VP), parkinsonism resulting from ischemic cerebrovascular disease, was
      suggested in 1929. The main features are wide-based gait, postural instability, and falls,
      which make patients with VP frustrated. Currently, the treatment is challenging.

      Transcranial magnetic stiumation is a noninvasive procedure using electromagnetic induction
      to stimulate brain, and repetitive transcranial magnetic stiumation (rTMS) can selectively
      change brain activity to enhance desired effects. The aim of this study is to explore the
      therapeutic effect of rTMS for the VP.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2018</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Unified Parkinson's Disease Rating Scale (UPDRS) part III-motor part (Number 18 ~31 of UPDRS)</measure>
    <time_frame>2 days</time_frame>
    <description>Motor functions will be checked using UPDRS. Each item of the motor part ranges from 0 to 4 (0 means normal, 4 means worst condition). Total sum will be calculated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Finger tapping test with right hand</measure>
    <time_frame>2 days</time_frame>
    <description>Finger tapping test with right hand, as quickly as possible for 15 second. The total number of taps will be calculated. The test will be twice with one minute interval. After the test performed twice, the average of the tests will be used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The total number of steps during the stand-walk-sit (SWS) test</measure>
    <time_frame>2 days</time_frame>
    <description>SWS test is Standing up, making a 9 m round trip, and sitting down as quickly as possible. The number of steps will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The completion time during the SWS test</measure>
    <time_frame>2 days</time_frame>
    <description>The completion time will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Freezing episodes of gait trajectory</measure>
    <time_frame>2 days</time_frame>
    <description>The number of freezing episodes during rapid full turns and dual task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient and Clinical Global Impression Scale</measure>
    <time_frame>2 days</time_frame>
    <description>7-point scale that requires the patient (or clinician) to rate the response of the interventions. The rating will be numbered (1: very much improved; 2: much improved; 3: minimally improved; 4: no changes; 5: minimally worse; 6: much worse; 7: very much worse).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Vascular Parkinsonism</condition>
  <arm_group>
    <arm_group_label>Real rTMS Supplementary motor area</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Real rTMS will be applied over the supplementary motor area</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham rTMS Supplementary motor area</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham rTMS will be applied over the supplementary motor area</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Real rTMS Supplementary motor area</intervention_name>
    <description>There will be a series of four rTMS blocks separated by 10 minutes. Each block will consist of 15 to 25 pulse trains of 1-second duration at 25 Hz, with an intertrain interval of 10 seconds.</description>
    <arm_group_label>Real rTMS Supplementary motor area</arm_group_label>
    <other_name>Real repetitive transcranial magnetic stimulation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham rTMS Supplementary motor area</intervention_name>
    <description>There will be no real brain stimulation in Sham rTMS, and participant will be blinded.</description>
    <arm_group_label>Sham rTMS Supplementary motor area</arm_group_label>
    <other_name>Sham repetitive transcranial magnetic stimulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Vascular parkinsonism

          -  age 18 and older

        Exclusion Criteria:

          -  pregnant or any, other medical, surgical, neurological or psychiatric conditions

          -  other restrictions which prevent you from undergoing TMS recording, such as;
             surgically or traumatically implanted foreign bodies such as a pacemaker, an implanted
             medication pump, a metal plate in the skull, or metal inside the skull or eyes (other
             than dental appliances or fillings), and/ or heart/cardiac lines

          -  any past or current history of seizure disorder or epilepsy

          -  unable to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sang Jin Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje Unversity, Busan Paik Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sang Jin Kim, MD, PhD</last_name>
    <phone>82-51-890-8954</phone>
    <email>jsk120@hanmail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Inje university, Busan Paik Hospital</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 22, 2018</study_first_submitted>
  <study_first_submitted_qc>October 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2018</study_first_posted>
  <last_update_submitted>October 27, 2018</last_update_submitted>
  <last_update_submitted_qc>October 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Sangjin Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>parkinsonism</keyword>
  <keyword>vascular parkinsonism</keyword>
  <keyword>repetitive transcranial magnetic stimulation</keyword>
  <keyword>brain stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinsonian Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

